These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 30167910)

  • 1. Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer.
    Nishigori T; Tsunoda S; Obama K; Hisamori S; Hashimoto K; Itatani Y; Okada K; Sakai Y
    Ann Surg Oncol; 2018 Nov; 25(12):3596-3603. PubMed ID: 30167910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
    Kim J; Han SH; Kim HI
    J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center.
    Zheng ZF; Lu J; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Huang CM
    Ann Surg Oncol; 2017 Jul; 24(7):1795-1803. PubMed ID: 28213789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative skeletal muscle index and visceral-to-subcutaneous fat area ratio are associated with long-term outcomes of elderly gastric cancer patients after gastrectomy.
    Taki Y; Sato S; Nakatani E; Higashizono K; Nagai E; Nishida M; Watanabe M; Ohata K; Kanemoto H; Oba N
    Langenbecks Arch Surg; 2021 Mar; 406(2):463-471. PubMed ID: 33515316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
    Park HS; Kim HS; Beom SH; Rha SY; Chung HC; Kim JH; Chun YJ; Lee SW; Choe EA; Heo SJ; Noh SH; Hyung WJ; Cheong JH; Kim HI; Son T; Lim JS; Baek SE; Jung M
    Ann Surg Oncol; 2018 Oct; 25(11):3222-3230. PubMed ID: 30051367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study.
    Kim KW; Lee K; Lee JB; Park T; Khang S; Jeong H; Ko CS; Yook JH; Kim BS; Lee IS
    BMC Cancer; 2021 Feb; 21(1):157. PubMed ID: 33579228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle Mass, Density, and Strength Are Necessary to Diagnose Sarcopenia in Patients With Gastric Cancer.
    Lin J; Zhang W; Chen W; Huang Y; Wu R; Chen X; Shen X; Zhu G
    J Surg Res; 2019 Sep; 241():141-148. PubMed ID: 31022680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer.
    Lee JS; Kim YS; Kim EY; Jin W
    PLoS One; 2018; 13(8):e0202700. PubMed ID: 30125312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.
    Tegels JJ; van Vugt JL; Reisinger KW; Hulsewé KW; Hoofwijk AG; Derikx JP; Stoot JH
    J Surg Oncol; 2015 Sep; 112(4):403-7. PubMed ID: 26331988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of preoperative skeletal muscle status in patients with gastric cancer after radical gastrectomy.
    Hu CL; Jin XH; Yuan ZD; Xiong SW; Zhang L; Hou JN; Ao S; Wu JL; Shi HP; Ji JF; Lyv GQ
    Asia Pac J Clin Nutr; 2019; 28(3):442-449. PubMed ID: 31464390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Sarcopenia, Myosteatosis, and the Prognostic Nutritional Index on Survival in Stage 2 and 3 Gastric Cancer Patients.
    Bir Yucel K; Karabork Kilic AC; Sutcuoglu O; Yazıcı O; Aydos U; Kilic K; Özdemir N
    Nutr Cancer; 2023; 75(1):368-375. PubMed ID: 36093734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Preoperative Skeletal Muscle Measure as a Predictor of Postoperative Complications, Long-Term Survival and Tumor Recurrence for Patients with Gastric Cancer After Radical Gastrectomy.
    Lu J; Zheng ZF; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM
    Ann Surg Oncol; 2018 Feb; 25(2):439-448. PubMed ID: 29181681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of surgery-induced sarcopenia in the survival of gastric cancer patients: a sex-specific analysis.
    Lee JK; Park YS; Lee K; Youn SI; Won Y; Min SH; Ahn SH; Park DJ; Kim HH
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1897-1907. PubMed ID: 34533290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes.
    Kuwada K; Kuroda S; Kikuchi S; Yoshida R; Nishizaki M; Kagawa S; Fujiwara T
    Ann Surg Oncol; 2018 May; 25(5):1160-1166. PubMed ID: 29404820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter study to define sarcopenia in patients with end-stage liver disease.
    Carey EJ; Lai JC; Wang CW; Dasarathy S; Lobach I; Montano-Loza AJ; Dunn MA;
    Liver Transpl; 2017 May; 23(5):625-633. PubMed ID: 28240805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy.
    Shi B; Liu S; Chen J; Liu J; Luo Y; Long L; Lan Q; Zhang Y
    Ann Nutr Metab; 2019; 75(4):213-222. PubMed ID: 31846973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EWGSOP2 versus EWGSOP1 for sarcopenia to predict prognosis in patients with gastric cancer after radical gastrectomy: Analysis from a large-scale prospective study.
    Zhuang CL; Shen X; Zou HB; Dong QT; Cai HY; Chen XL; Yu Z; Wang SL
    Clin Nutr; 2020 Jul; 39(7):2301-2310. PubMed ID: 31732287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer.
    Chan WL; Yun HB; Cheung EE; Liu M; Hou LY; Lam KO; Wong IY; Chiu WK; Law S; Kwong D
    Oncologist; 2024 Oct; 29(10):e1272-e1279. PubMed ID: 38885304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal Muscle Mass Depletion After Gastrectomy Negatively Affects the Prognosis of Patients With Gastric Cancer.
    Kanazawa Y; Yamada T; Kakinuma D; Matsuno K; Ando F; Fujita I; Kanno H; Kato S; Yoshida H
    Anticancer Res; 2020 Aug; 40(8):4271-4279. PubMed ID: 32727754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.